Get the Stockscreener App
44.30
1.86%
0.81
Atricure Inc stock is traded at $44.30, with a volume of 340.86K.
It is up +1.86% in the last 24 hours and up +29.08% over the past month.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
See More
Previous Close:
$43.49
Open:
$43.71
24h Volume:
340.86K
Relative Volume:
0.38
Market Cap:
$2.25B
Revenue:
$534.53M
Net Income/Loss:
$-11.45M
P/E Ratio:
-183.74
EPS:
-0.2411
Net Cash Flow:
$48.28M
1W Performance:
+7.03%
1M Performance:
+29.08%
6M Performance:
+35.68%
1Y Performance:
+25.11%
1-Day Range:
$43.22
$44.48
1-Week Range:
$41.01
$44.48
52-Week Range:
$25.36
$44.48
Atricure Inc Stock (ATRC) Company Profile
Name
Atricure Inc
Sector
Industry
Phone
513-755-4100
Address
7555 INNOVATION WAY, MASON, OH
Compare ATRC vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
44.30 | 2.22B | 534.53M | -11.45M | 48.28M | -0.2411 |
ISRG
Intuitive Surgical Inc
|
394.51 | 141.76B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
183.40 | 50.00B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
74.25 | 35.57B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
224.46 | 32.78B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.74 | 31.15B | 29.14B | 1.07B | 1.05B | 1.1956 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-18-26 | Downgrade | Oppenheimer | Outperform → Perform |
| Feb-11-26 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-17-24 | Resumed | JP Morgan | Overweight |
| Apr-23-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Oct-23-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-29-23 | Initiated | UBS | Buy |
| Aug-05-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Dec-18-20 | Reiterated | Needham | Buy |
| Nov-06-20 | Reiterated | Needham | Buy |
| Apr-07-20 | Initiated | Oppenheimer | Outperform |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jan-24-20 | Reiterated | Needham | Buy |
| Aug-13-19 | Downgrade | Northland Capital | Outperform → Market Perform |
| Apr-12-19 | Initiated | JP Morgan | Overweight |
| Oct-04-18 | Reiterated | Needham | Buy |
| Aug-02-18 | Reiterated | Needham | Buy |
| Aug-02-18 | Reiterated | Stifel | Buy |
| Jun-18-18 | Reiterated | Needham | Buy |
| Apr-27-18 | Reiterated | Needham | Buy |
| Jan-16-18 | Reiterated | Needham | Buy |
| Nov-02-17 | Reiterated | Needham | Buy |
| Jul-28-17 | Reiterated | Needham | Buy |
| May-30-17 | Resumed | Piper Jaffray | Overweight |
| Jun-30-16 | Resumed | JMP Securities | Mkt Outperform |
| Oct-28-15 | Reiterated | Needham | Buy |
| Oct-06-15 | Reiterated | Canaccord Genuity | Buy |
| Oct-06-15 | Reiterated | Needham | Buy |
View All
Atricure Inc Stock (ATRC) Latest News
AtriCure stock hits 52-week high at $43.19 By Investing.com - Investing.com Australia
AtriCure stock hits 52-week high at $43.19 - Investing.com
AtriCure, Inc.Common Stock (ATRC) Stock Price, News, Quote & History - FinancialContent
AtriCure Targets $1 Billion as Pain Management and AFib Trials Fuel Growth - Yahoo Finance
A Look at AtriCure Inc (ATRC) After 3.1% Gain -- GF Value $39.42 vs Price $42.95 - GuruFocus
AtriCure (NASDAQ:ATRC) Sets New 12-Month HighHere's Why - MarketBeat
ATRC: Strong growth, innovation, and clinical trial catalysts drive robust financial and market expansion - TradingView
AtriCure Inc (ATRC) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
Discipline and Rules-Based Execution in ATRC Response - Stock Traders Daily
AtriCure director Karen Prange sells $138,283 in stock By Investing.com - Investing.com UK
AtriCure Inc (ATRC) Stock News Today - tradingkey.com
Two AtriCure Directors Trimmed Shares After a Strong Quarter. Here's What Matters for Investors - The Motley Fool
An AtriCure Director Sold $905,000 in Stock. Here's How to Read It - The Motley Fool
AtriCure director Maggie Yuen sells $134,470 in stock By Investing.com - Investing.com South Africa
AtriCure Inc (ATRC) Director Karen Prange Sells 3,564 Shares - GuruFocus
AtriCure (NASDAQ:ATRC) Director Sells 3,500 Shares - MarketBeat
AtriCure (NASDAQ:ATRC) Director Sells $138,283.20 in Stock - MarketBeat
AtriCure director Maggie Yuen sells $134,470 in stock - Investing.com
Director At AtriCure Sells $134K Of Stock - benzinga.com
AtriCure director Karen Prange sells $138,283 in stock - Investing.com
AtriCure, Inc. (ATRC) director sells 3,564 shares at $38.80 - Stock Titan
AtriCure (ATRC) director Maggie Yuen reports sale of 3,500 shares - Stock Titan
AtriCure, Inc. (NASDAQ:ATRC) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
AtriCure director Maggie Yuen sells 3,500 shares worth $134,470 - Bitget
AtriCure, Inc. SEC Filing (Aug 5, 2026) - Stock Titan
AtriCure (ATRC) insider plans NASDAQ sale of 3,564 awarded shares - Stock Titan
We Think AtriCure's (NASDAQ:ATRC) Profit Is Only A Baseline For What They Can Achieve - Moomoo
AtriCure, Inc. (ATRC) Stock Analysis: Exploring a Potential 22.25% Upside in the Healthcare Sector - directorstalkinterviews.com
AtriCure, Inc. $ATRC Stock Position Raised by First Trust Advisors LP - MarketBeat
Will AtriCure’s (ATRC) Profit Turn and ESOP Share Plans Recast Its Investment Narrative? - simplywall.st
Form 4 AtriCure Inc For: 3 August By Investing.com - Investing.com Nigeria
AtriCure, Inc. (ATRC) CEO makes 4,700-share stock gifts to family, charity - Stock Titan
AtriCure CEO Michael Carrel Donates 4,700 Shares of Common Stock - Kalkine Media
A Look at AtriCure Inc (ATRC) After 6.0% Decline -- GF Value $39 - GuruFocus
Board Member At AtriCure Exercises Options Worth $491K - benzinga.com
Insider Selling: Vinayak Doraiswamy Unloads $233K Of AtriCure Stock - Benzinga
AtriCure (ATRC) Insider Sale: Chief Mktg & Strategy Officer Just - GuruFocus
AtriCure (NASDAQ: ATRC) director exercises 25,000 options and sells 25,000 shares - Stock Titan
Sven Wehrwein Sells 25,000 Shares of AtriCure (NASDAQ:ATRC) Stock - MarketBeat
Form 144 AtriCure For: 29 July By Investing.com - Investing.com Nigeria
ATRC: Targeting $1B revenue by 2030, driven by innovation in Afib and pain management solutions - TradingView
Behavioral Patterns of ATRC and Institutional Flows - Stock Traders Daily
Inspire Medical Systems appoints Michael H. Carrel to its board - Medical Buyer
AtriCure, Inc. (ATRC) Beat Earnings Estimates. Here’s What Could Drive ATRC Stock Next - Yahoo Finance
ATRC Maintained by UBS -- Price Target Lowered to $50.00 - GuruFocus
ATRC SWOT Analysis: Strong Revenue Growth and Innovation Highlig - GuruFocus
AtriCure, Inc. (ATRC) Q2 2026 10-Q Report: Financial Performance, Earnings, and Stockholder Updates - Minichart
AtriCure CEO Carrel joins Inspire Medical board of directors - MassDevice
AtriCure, Inc. 2026: Revenue $153.6M, EPS $0.18— 10-Q Summary - TradingView
[10-Q] AtriCure, Inc. Quarterly Earnings Report - Stock Titan
Inspire Medical Systems adds AtriCure CEO to board - Investing.com
Atricure Inc Stock (ATRC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.90%
1.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):